Loading...
FDA drug summaries: a simplification too far?
Authors
Advisor
Date
2015-06-12
Embargo until
Language
Book title
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
The FDA has launched a new tool to help patients understand a drug’s risks and benefits. However, Peter Doshi speculates that in an effort to keep the content simple important information is being left out
Citations
Altmetric: